Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Actinium Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01756677
First received: December 20, 2012
Last updated: April 2, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)